According to P&S Intelligence, the growing awareness about drug and alcohol addiction among the youth, technological improvements in drug of abuse (DOA) testing products, and rising government initiatives are some notable factors strengthening the European drug of abuse testing market. The market generated a revenue of $1.7 billion in 2017, and is expected to progress at a CAGR of 9.6% during the forecast period (2018–2023).
Request for report sample at: https://www.psmarketresearch.com/market-analysis/europe-doa-testing-market/report-sample
Drug testing refers to the technical analysis of a biological specimen, such as saliva, urine, sweat, blood and breath, to detect the presence of cannabis, cocaine, and alcohol. The European DOA testing market is segmented by offering, sample type, distribution channel, and end user. Based on the offering, the market is categorized into products and services. Of these, during the 2018–2023 period, the services category is predicted to witness faster growth (CAGR of 11.1%) and expected to generate a revenue of more than $600.0 million by 2023.
This can be ascribed to the implementation of the drug testing policy in workplaces and increasing focus of the major market players on offering testing kits and services. Coming to the sample type, urine, saliva, hair, and other body samples are used for DOA testing. Among these, urine samples have been the most widely used for testing drugs in the European drug of abuse (DOA) testing market, dominating it with a 83.8% share.
On the basis of distribution channel, in 2017, between the direct and indirect modes, the indirect channel dominated the market with more than 55.0% share. Further, the end users of the European DOA testing market are hospitals, workplaces, laboratories, and at-home. Out of these, the hospitals section held around 43.0% share in the market. Due to the availability of skilled professionals at hospitals and the rising government initiatives to improve the healthcare infrastructure, this section is witnessing growth.
Browse full report at: https://www.psmarketresearch.com/market-analysis/europe-doa-testing-market
Now, one of the key factors driving the market growth is technological advancements, which are boosting the testing product usage in multiple healthcare settings. To increase the sensitivity and offer detection of newly developed designer drugs, the testing products are being advanced. Also, the growing adoption of these products for medical and legal purposes has made it imperative to produce results with high confidence levels. For instance, smartphone breath analyzers, such as DrinkMate and BACtrack, are available in the market for testing breath alcohol content. These devices are handy and can transmit results via the wireless technology.
Hence, with the increasing number of product launches and rapid advancements in technology, the drug of abuse testing market in Europe is expected to witness a steady growth during the forecast period.
Company Name: P&S Intelligence
Contact Person: Abhishek
Email: Send Email
Country: United States